ACE2 and COVID-19: In fact, while some data suggest that an increased expression of ACE2 favors the progression of the disease [52], others indicate that COVID-19 leads to a reduction of ACE2 activity in elderly individuals with chronic diseases, resulting in angiotensin II/ACE2 regulation imbalance and loss of ACE2 protective effects [54].